advertisement
14 Costing studies; pharmacoeconomics (7)
Showing records 1 to 7
Display all abstracts in classification 14 Costing studies; pharmacoeconomics
Search within classification 14 Costing studies; pharmacoeconomics13266 A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy
Christensen TL; Poulsen PB; Holmstrom S; Walt JG; Vetrugno M
Current Medical Research and Opinion 2005; 21: 1837-1843
13267 The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients - a European perspective
Tuil E; Hommer AB; Poulsen PB; Christensen TL; Buchholz P; Walt J; Holmstrom S
International Journal of Clinical Pract 2005; 59: 1011-1016
13351 Can the number of primary open angle glaucoma in Austria within 2001 to 2031 be estimated?
Hitzl W; Reitsamer HA; Grabner G; Hornykewcyz K
Spektrum der Augenheilkunde 2005; 19: 290-293
13437 The rising cost of glaucoma drugs in Ireland 1996-2003
Knox FA; Barry M; McGowan B; O'Brien C
British Journal of Ophthalmology 2006; 90: 162-165
13452 A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD
Archives of Ophthalmology 2006; 124: 12-19
13429 A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D
Acta Ophthalmologica Scandinavica 2006; 84: 74-83
13411 Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications
Noecker RJ; Walt JG
American Journal of Ophthalmology 2006; 141: S15-S21